 Illumina Inc NASDAQ:ILMN shares are due to plummet on Friday after the gene sequencing company swung to a loss in the second quarter as revenue fell short of expectations and it cut its full-year outlook. Revenue grew 3 year over year to US1.16bn, up 5 on a constant-currency basis, but lower than the consensus estimate of US1.22bn. 